General Information of Drug (ID: DM9H6GO)

Drug Name
BIIB061
Indication
Disease Entry ICD 11 Status REF
Multiple sclerosis 8A40 Phase 1 [1]
Cross-matching ID
TTD ID
D09ALM

References

1 ClinicalTrials.gov (NCT02071121) Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect. U.S. National Institutes of Health.